Page last updated: 2024-10-22

ag-1296 and Respiratory Distress Syndrome

ag-1296 has been researched along with Respiratory Distress Syndrome in 1 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"91% in acute respiratory distress syndrome patients; p = ."1.38Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*. ( Bouadma, L; Crestani, B; Dehoux, M; Lasocki, S; Leçon, V; Mailleux, A; Nardelli, L; Philip, I; Piednoir, P; Quesnel, C; Soler, P, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piednoir, P1
Quesnel, C1
Nardelli, L1
Leçon, V1
Bouadma, L1
Lasocki, S1
Philip, I1
Mailleux, A1
Soler, P1
Crestani, B1
Dehoux, M1

Other Studies

1 other study available for ag-1296 and Respiratory Distress Syndrome

ArticleYear
Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.
    Critical care medicine, 2012, Volume: 40, Issue:7

    Topics: Acute Lung Injury; Aged; Blotting, Western; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Ce

2012